Background: Diabetic neuropathy (DN) may impair balance and gait, increasing the risk of falls in elderly patients with type 2 diabetes mellitus (T2DM). This study aimed to evaluate whether the presence and severity of DN are associated with balance and mobility impairment as well as with increased fear of falling in patients with T2DM. Methods: A total of 124 adults with T2DM underwent neuropathy assessment with the Michigan Neuropathy Screening Instrument (MNSI) and sudomotor testing (SUDOSCAN). Balance and fall risk were evaluated using the Berg Balance Scale (BBS), Timed Up and Go (TUG), Falls Efficacy Scale—International (FES-I), and Fear of Falling Questionnaire—Revised (FFQ-R). Comparison of parameters between patients with vs. without DN, correlations, and multivariable linear regressions (DN components as predictors) were performed. Results: Compared with those without DN, participants with DN had higher FES-I (31.0 vs. 21.0) and FFQ-R (56.0 vs. 42.0) scores and lower BBS (42.0 vs. 46.0). TUG did not differ significantly (11.8 vs. 11.25 s). In multivariable models, higher MNSI questionnaire and objective scores independently predicted lower BBS (β = −0.74 and −1.1, respectively) while only the MNSI questionnaire predicted higher TUG (β = 0.43). For fear of falling, the MNSI questionnaire predicted higher FES-I (β = 1.66) and both MNSI components predicted higher FFQ-R (β = 2.31 and 1.7, respectively). Leg SUDOSCAN values were not associated with BBS, TUG, FES-I, or FFQ-R. Conclusions: DN is associated with impaired balance and greater fear of falling. Neuropathy burden, particularly patient-reported symptoms, relates to worse performance and confidence, whereas sudomotor impairment alone does not.

Background: Fear of falling is common in older adults with type 2 diabetes mellitus (T2DM), particularly in those with balance and mobility impairment. The Falls Efficacy Scale—International (FES-I) is widely used to quantify concern about falling but requires local validation. We aimed to validate the Romanian version of the FES-I in older adults with T2DM. Methods: In this validation study, 124 consecutive outpatients with T2DM aged > 60 years completed the Romanian FES-I at baseline (v1) and at one-month follow-up (v2). Internal consistency was assessed with Cronbach’s alpha and item–total correlations. Test–retest reliability was evaluated using intraclass correlation coefficient (ICC) and the Bland–Altman agreement. Construct validity was examined by correlations with the Fear-of-Falling Questionnaire—Revised (FFQ-R), Berg Balance Scale (BBS), Timed Up and Go (TUG), and single-leg stance (SLS). Discriminative performance was assessed via ROC analyses. Results: Mean FES-I scores were 30.8 ± 11.4 (v1) and 31.1 ± 11.6 (v2). Internal consistency (Cronbach’s alpha 0.945–0.947) and test–retest reliability (ICC 0.972; 95% CI 0.956–0.983) were excellent, with minimal bias. FES-I correlated strongly with FFQ-R (rho = 0.787) and moderately with function (BBS rho = −0.631; TUG rho = 0.547; SLS rho = −0.498; all p < 0.001). Discrimination was good for BBS (AUROC = 0.779) and TUG (AUROC = 0.800). Conclusions: The Romanian FES-I demonstrates excellent reliability and good validity in older adults with T2DM, with low measurement error and clinically interpretable change thresholds. It can be used for fear-of-falling quantification in routine care and research, including longitudinal monitoring and evaluation of interventions in Romanian patients with diabetes.

Background/Objectives: Orthostatic hypotension (OH) is a clinically relevant manifestation that may reflect cardiovascular autonomic dysfunction in type 2 diabetes (T2D), yet its correlates remain incompletely characterized. This cross-sectional study evaluated clinical, neuropathic, and sudomotor factors associated with OH and explored balance-related outcomes as secondary analyses. Methods: In this cross-sectional study, 124 adults with T2D aged ≥60 years underwent standardized orthostatic blood pressure testing. Peripheral neuropathy was assessed using the Michigan Neuropathy Screening Instrument (MNSI), and sudomotor function was assessed by electrochemical skin conductance measured with Sudoscan. Balance, mobility, and fear of falling were evaluated as exploratory secondary outcomes. Active antihypertensive treatment was recorded at the time of assessment and considered a potential confounder. Multivariable logistic regression was used to identify factors associated with OH. Results: OH was associated with longer diabetes duration (OR = 1.11/year, p = 0.002), higher objective neuropathy severity (MNSI-B; OR = 1.27, p = 0.049), and increased urinary albumin-to-creatinine ratio (OR = 1.01, p = 0.035). Sudomotor parameters did not differ significantly between OH groups in univariate analyses and were not retained in the final parsimonious model. Exploratory analyses showed no significant univariate differences in balance or fear-of-falling outcomes by OH status. Model discrimination was acceptable (AUC = 0.787), whereas calibration was imperfect according to the Hosmer–Lemeshow test; therefore, model performance should be interpreted as apparent and explanatory rather than predictive. Conclusions: In older adults with T2D, OH was associated with longer disease duration, greater neuropathy burden, and microvascular involvement. Sudoscan-derived measures were not independently associated with OH in this cohort. Because of the cross-sectional design and residual medication confounding, all findings should be interpreted as associations only. These results support routine orthostatic evaluation alongside neuropathy and albuminuria assessment, while predictive modeling requires external validation in larger cohorts.